Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G
PROVECTUS BIOPHARMACEUTICALS, INC.
14 Aug 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
14 Aug 24
4
PROVECTUS BIOPHARMACEUTICALS, INC.
14 Aug 23
SC 13G
PROVECTUS BIOPHARMACEUTICALS, INC.
9 May 23
4
PROVECTUS BIOPHARMACEUTICALS, INC.
9 May 23
SC 13G
PROVECTUS BIOPHARMACEUTICALS, INC.
28 Mar 23
3
PROVECTUS BIOPHARMACEUTICALS, INC.
28 Mar 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Aug 24 | PVCT Provectus Biopharmaceuticals | Series D-1 Convertible Preferred Stock | Conversion | Acquire C | No | No | 2.862 | 264,314 | 756.47 k | 4,260,061 |
11 Aug 23 | PVCT Provectus Biopharmaceuticals | 8% Secured Convertible Promissory Note [object Object] | Grant | Acquire A | No | No | 2.862 | - | 700.00 k | 244,584 |
8 May 23 | PVCT Provectus Biopharmaceuticals | Series D-1 Convertible Preferred Stock | Conversion | Acquire C | No | No | 2.862 | 188,757 | 540.22 k | 3,995,747 |